nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfinpyrazone—ABCB1—colon cancer	0.256	1	CbGaD
Sulfinpyrazone—ABCC5—Fluorouracil—colon cancer	0.115	0.169	CbGbCtD
Sulfinpyrazone—ABCC3—Fluorouracil—colon cancer	0.0725	0.107	CbGbCtD
Sulfinpyrazone—ABCC3—Vincristine—colon cancer	0.066	0.097	CbGbCtD
Sulfinpyrazone—ABCC4—Fluorouracil—colon cancer	0.0554	0.0814	CbGbCtD
Sulfinpyrazone—ABCC1—Irinotecan—colon cancer	0.0464	0.0682	CbGbCtD
Sulfinpyrazone—ABCC1—Vincristine—colon cancer	0.0405	0.0596	CbGbCtD
Sulfinpyrazone—ABCC3—Methotrexate—colon cancer	0.04	0.0587	CbGbCtD
Sulfinpyrazone—ABCC2—Irinotecan—colon cancer	0.0343	0.0505	CbGbCtD
Sulfinpyrazone—ABCC4—Methotrexate—colon cancer	0.0305	0.0449	CbGbCtD
Sulfinpyrazone—ABCC2—Vincristine—colon cancer	0.03	0.0441	CbGbCtD
Sulfinpyrazone—ABCC1—Methotrexate—colon cancer	0.0245	0.0361	CbGbCtD
Sulfinpyrazone—CYP2B6—Irinotecan—colon cancer	0.0218	0.0321	CbGbCtD
Sulfinpyrazone—CYP2C9—Capecitabine—colon cancer	0.0187	0.0274	CbGbCtD
Sulfinpyrazone—ABCC2—Methotrexate—colon cancer	0.0182	0.0267	CbGbCtD
Sulfinpyrazone—CYP2C8—Fluorouracil—colon cancer	0.0159	0.0233	CbGbCtD
Sulfinpyrazone—ABCB1—Irinotecan—colon cancer	0.0112	0.0164	CbGbCtD
Sulfinpyrazone—CYP2C9—Fluorouracil—colon cancer	0.0111	0.0163	CbGbCtD
Sulfinpyrazone—ABCB1—Vincristine—colon cancer	0.00978	0.0144	CbGbCtD
Sulfinpyrazone—CYP3A4—Irinotecan—colon cancer	0.0067	0.00985	CbGbCtD
Sulfinpyrazone—ABCB1—Methotrexate—colon cancer	0.00592	0.0087	CbGbCtD
Sulfinpyrazone—CYP3A4—Vincristine—colon cancer	0.00586	0.00861	CbGbCtD
Sulfinpyrazone—ABCC2—bile—colon cancer	0.0057	0.11	CbGeAlD
Sulfinpyrazone—FABP2—embryo—colon cancer	0.00527	0.101	CbGeAlD
Sulfinpyrazone—FABP2—epithelium—colon cancer	0.0043	0.0828	CbGeAlD
Sulfinpyrazone—SLC22A12—renal system—colon cancer	0.00399	0.0768	CbGeAlD
Sulfinpyrazone—SLC22A12—digestive system—colon cancer	0.00327	0.063	CbGeAlD
Sulfinpyrazone—FABP2—digestive system—colon cancer	0.00327	0.063	CbGeAlD
Sulfinpyrazone—ABCC3—gall bladder—colon cancer	0.00198	0.0381	CbGeAlD
Sulfinpyrazone—FABP2—lymph node—colon cancer	0.00187	0.036	CbGeAlD
Sulfinpyrazone—ABCC6—renal system—colon cancer	0.00166	0.032	CbGeAlD
Sulfinpyrazone—ABCC6—liver—colon cancer	0.00102	0.0196	CbGeAlD
Sulfinpyrazone—ABCC3—renal system—colon cancer	0.00095	0.0183	CbGeAlD
Sulfinpyrazone—ABCC5—bone marrow—colon cancer	0.000855	0.0165	CbGeAlD
Sulfinpyrazone—ABCC5—vagina—colon cancer	0.000819	0.0158	CbGeAlD
Sulfinpyrazone—ABCC4—renal system—colon cancer	0.000784	0.0151	CbGeAlD
Sulfinpyrazone—ABCC3—digestive system—colon cancer	0.000779	0.015	CbGeAlD
Sulfinpyrazone—ABCC2—renal system—colon cancer	0.000759	0.0146	CbGeAlD
Sulfinpyrazone—ABCC5—liver—colon cancer	0.000691	0.0133	CbGeAlD
Sulfinpyrazone—ABCC4—digestive system—colon cancer	0.000643	0.0124	CbGeAlD
Sulfinpyrazone—ABCC3—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000629	0.0558	CbGpPWpGaD
Sulfinpyrazone—ABCC2—digestive system—colon cancer	0.000623	0.012	CbGeAlD
Sulfinpyrazone—ABCB1—blood vessel—colon cancer	0.000605	0.0116	CbGeAlD
Sulfinpyrazone—ABCC4—bone marrow—colon cancer	0.000593	0.0114	CbGeAlD
Sulfinpyrazone—ABCC3—liver—colon cancer	0.00058	0.0112	CbGeAlD
Sulfinpyrazone—CYP2C8—renal system—colon cancer	0.000569	0.011	CbGeAlD
Sulfinpyrazone—ABCC6—ABC-family proteins mediated transport—ABCB1—colon cancer	0.000558	0.0495	CbGpPWpGaD
Sulfinpyrazone—ABCC5—lymph node—colon cancer	0.00053	0.0102	CbGeAlD
Sulfinpyrazone—CYP2B6—renal system—colon cancer	0.000511	0.00983	CbGeAlD
Sulfinpyrazone—ABCC2—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000499	0.0442	CbGpPWpGaD
Sulfinpyrazone—ABCC1—vagina—colon cancer	0.000484	0.00932	CbGeAlD
Sulfinpyrazone—ABCC4—liver—colon cancer	0.000479	0.00922	CbGeAlD
Sulfinpyrazone—ABCC2—liver—colon cancer	0.000464	0.00893	CbGeAlD
Sulfinpyrazone—ABCC3—lymph node—colon cancer	0.000445	0.00857	CbGeAlD
Sulfinpyrazone—CYP2B6—lymphoid tissue—colon cancer	0.000424	0.00816	CbGeAlD
Sulfinpyrazone—CYP2B6—digestive system—colon cancer	0.000419	0.00806	CbGeAlD
Sulfinpyrazone—CYP2C9—digestive system—colon cancer	0.000415	0.00798	CbGeAlD
Sulfinpyrazone—CYP2C8—vagina—colon cancer	0.000412	0.00794	CbGeAlD
Sulfinpyrazone—ABCC1—liver—colon cancer	0.000409	0.00786	CbGeAlD
Sulfinpyrazone—CYP3A4—renal system—colon cancer	0.000386	0.00742	CbGeAlD
Sulfinpyrazone—ABCC5—Defective B3GAT3 causes JDSSDHD—CHST5—colon cancer	0.000372	0.033	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—vagina—colon cancer	0.00037	0.00712	CbGeAlD
Sulfinpyrazone—ABCC4—lymph node—colon cancer	0.000367	0.00707	CbGeAlD
Sulfinpyrazone—ABCB1—embryo—colon cancer	0.000361	0.00694	CbGeAlD
Sulfinpyrazone—ABCC2—lymph node—colon cancer	0.000356	0.00684	CbGeAlD
Sulfinpyrazone—CYP2C8—liver—colon cancer	0.000348	0.0067	CbGeAlD
Sulfinpyrazone—ABCC3—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000344	0.0305	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000324	0.0287	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—digestive system—colon cancer	0.000316	0.00609	CbGeAlD
Sulfinpyrazone—ABCC1—lymph node—colon cancer	0.000313	0.00603	CbGeAlD
Sulfinpyrazone—CYP2B6—liver—colon cancer	0.000312	0.00601	CbGeAlD
Sulfinpyrazone—CYP2C9—liver—colon cancer	0.000309	0.00595	CbGeAlD
Sulfinpyrazone—ABCB1—epithelium—colon cancer	0.000294	0.00566	CbGeAlD
Sulfinpyrazone—ABCB1—renal system—colon cancer	0.000273	0.00525	CbGeAlD
Sulfinpyrazone—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000273	0.0242	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Fluoropyrimidine Activity—TYMS—colon cancer	0.00027	0.0239	CbGpPWpGaD
Sulfinpyrazone—ABCC5—ABC-family proteins mediated transport—ABCB1—colon cancer	0.000256	0.0227	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—liver—colon cancer	0.000236	0.00454	CbGeAlD
Sulfinpyrazone—ABCC2—Irinotecan Pathway—APC—colon cancer	0.00023	0.0204	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Irinotecan Pathway—APC—colon cancer	0.000227	0.0201	CbGpPWpGaD
Sulfinpyrazone—ABCB1—lymphoid tissue—colon cancer	0.000227	0.00436	CbGeAlD
Sulfinpyrazone—ABCB1—digestive system—colon cancer	0.000224	0.00431	CbGeAlD
Sulfinpyrazone—CYP2B6—Metapathway biotransformation—CHST4—colon cancer	0.000222	0.0197	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000208	0.0184	CbGpPWpGaD
Sulfinpyrazone—ABCB1—bone marrow—colon cancer	0.000206	0.00397	CbGeAlD
Sulfinpyrazone—ABCC5—Carbohydrate metabolism—CHST5—colon cancer	0.0002	0.0177	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Fluoropyrimidine Activity—TYMS—colon cancer	0.000199	0.0176	CbGpPWpGaD
Sulfinpyrazone—ABCB1—vagina—colon cancer	0.000198	0.00381	CbGeAlD
Sulfinpyrazone—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000198	0.0175	CbGpPWpGaD
Sulfinpyrazone—ABCC3—ABC-family proteins mediated transport—ABCB1—colon cancer	0.000189	0.0168	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metapathway biotransformation—CHST4—colon cancer	0.000188	0.0167	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Fluoropyrimidine Activity—TYMS—colon cancer	0.000187	0.0166	CbGpPWpGaD
Sulfinpyrazone—ABCC4—ABC-family proteins mediated transport—ABCB1—colon cancer	0.000178	0.0158	CbGpPWpGaD
Sulfinpyrazone—Phenylbutazone—PTGS2—colon cancer	0.000169	0.568	CrCbGaD
Sulfinpyrazone—ABCB1—liver—colon cancer	0.000167	0.00321	CbGeAlD
Sulfinpyrazone—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000165	0.0146	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000157	0.0139	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metapathway biotransformation—CHST4—colon cancer	0.000153	0.0136	CbGpPWpGaD
Sulfinpyrazone—ABCC2—ABC-family proteins mediated transport—ABCB1—colon cancer	0.00015	0.0133	CbGpPWpGaD
Sulfinpyrazone—ABCC1—ABC-family proteins mediated transport—ABCB1—colon cancer	0.000148	0.0131	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000144	0.0128	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000138	0.0122	CbGpPWpGaD
Sulfinpyrazone—ABCC1—S1P1 pathway—PTGS2—colon cancer	0.000135	0.012	CbGpPWpGaD
Sulfinpyrazone—Clotrimazole—ABCB1—colon cancer	0.000129	0.433	CrCbGaD
Sulfinpyrazone—ABCB1—lymph node—colon cancer	0.000128	0.00246	CbGeAlD
Sulfinpyrazone—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000109	0.00967	CbGpPWpGaD
Sulfinpyrazone—ABCC1—S1P1 pathway—VEGFA—colon cancer	0.000106	0.00944	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000105	0.0093	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metapathway biotransformation—CHST5—colon cancer	0.000102	0.00904	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000101	0.00895	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	9.99e-05	0.00886	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Fluoropyrimidine Activity—TP53—colon cancer	8.95e-05	0.00794	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metapathway biotransformation—CHST5—colon cancer	8.63e-05	0.00766	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	7.91e-05	0.00701	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—CA7—colon cancer	7.83e-05	0.00695	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	7.23e-05	0.00641	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	7.02e-05	0.00623	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	6.95e-05	0.00617	CbGpPWpGaD
Sulfinpyrazone—ABCB1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	6.95e-05	0.00616	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	6.88e-05	0.00611	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Irinotecan Pathway—APC—colon cancer	6.66e-05	0.00591	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Fluoropyrimidine Activity—TP53—colon cancer	6.6e-05	0.00585	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—Transmembrane transport of small molecules—ABCB1—colon cancer	6.54e-05	0.0058	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Arachidonic acid metabolism—PTGS2—colon cancer	6.23e-05	0.00552	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Fluoropyrimidine Activity—TP53—colon cancer	6.2e-05	0.0055	CbGpPWpGaD
Sulfinpyrazone—ABCC6—Transmembrane transport of small molecules—ABCB1—colon cancer	5.83e-05	0.00517	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—CA7—colon cancer	5.77e-05	0.00512	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—LGR5—colon cancer	5.66e-05	0.00503	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—CHST5—colon cancer	5.66e-05	0.00503	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	5.17e-05	0.00459	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.13e-05	0.00455	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.79e-05	0.00425	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	4.77e-05	0.00423	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—ODC1—colon cancer	4.74e-05	0.00421	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—CHST5—colon cancer	4.74e-05	0.00421	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	4.63e-05	0.00411	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	4.54e-05	0.00403	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—CA7—colon cancer	4.52e-05	0.00401	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—AXIN2—colon cancer	4.07e-05	0.00361	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet degranulation—VEGFA—colon cancer	4.04e-05	0.00359	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	4e-05	0.00355	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	3.85e-05	0.00342	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet degranulation—TGFB1—colon cancer	3.71e-05	0.00329	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	3.53e-05	0.00313	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	3.53e-05	0.00313	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—CHST5—colon cancer	3.5e-05	0.0031	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—ODC1—colon cancer	3.5e-05	0.0031	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	3.4e-05	0.00302	CbGpPWpGaD
Sulfinpyrazone—ABCC5—NRF2 pathway—TGFB1—colon cancer	3.31e-05	0.00293	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—LGR5—colon cancer	3.27e-05	0.0029	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CHST5—colon cancer	3.27e-05	0.0029	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	3.16e-05	0.0028	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	2.97e-05	0.00263	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Ectoderm Differentiation—CTNNB1—colon cancer	2.97e-05	0.00263	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CA7—colon cancer	2.92e-05	0.00259	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	2.77e-05	0.00246	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—ODC1—colon cancer	2.74e-05	0.00243	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—CHST5—colon cancer	2.74e-05	0.00243	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—ABCB1—colon cancer	2.68e-05	0.00237	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CA7—colon cancer	2.47e-05	0.00219	CbGpPWpGaD
Sulfinpyrazone—ABCC3—NRF2 pathway—TGFB1—colon cancer	2.44e-05	0.00216	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Ectoderm Differentiation—MYC—colon cancer	2.4e-05	0.00213	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	2.37e-05	0.00211	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—AXIN2—colon cancer	2.35e-05	0.00209	CbGpPWpGaD
Sulfinpyrazone—ABCC4—NRF2 pathway—TGFB1—colon cancer	2.29e-05	0.00203	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	2.18e-05	0.00194	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CA7—colon cancer	2.15e-05	0.00191	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CA7—colon cancer	2.01e-05	0.00178	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—ABCB1—colon cancer	1.97e-05	0.00175	CbGpPWpGaD
Sulfinpyrazone—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	1.97e-05	0.00175	CbGpPWpGaD
Sulfinpyrazone—ABCC2—NRF2 pathway—TGFB1—colon cancer	1.93e-05	0.00171	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—CASP3—colon cancer	1.91e-05	0.00169	CbGpPWpGaD
Sulfinpyrazone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	1.87e-05	0.00166	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—ABCB1—colon cancer	1.86e-05	0.00165	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—SRC—colon cancer	1.84e-05	0.00163	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	1.82e-05	0.00161	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—VEGFA—colon cancer	1.79e-05	0.00159	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—ODC1—colon cancer	1.77e-05	0.00157	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CHST5—colon cancer	1.77e-05	0.00157	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	1.75e-05	0.00155	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—TGFB1—colon cancer	1.65e-05	0.00146	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—VEGFA—colon cancer	1.62e-05	0.00144	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.56e-05	0.00139	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—ABCB1—colon cancer	1.55e-05	0.00137	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ODC1—colon cancer	1.5e-05	0.00133	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CHST5—colon cancer	1.5e-05	0.00133	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.49e-05	0.00132	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.44e-05	0.00128	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	1.4e-05	0.00124	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.34e-05	0.00118	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CA7—colon cancer	1.33e-05	0.00118	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CHST5—colon cancer	1.3e-05	0.00116	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ODC1—colon cancer	1.3e-05	0.00116	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—ABCB1—colon cancer	1.25e-05	0.00111	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—TYMS—colon cancer	1.23e-05	0.00109	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—CHST5—colon cancer	1.22e-05	0.00108	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ODC1—colon cancer	1.22e-05	0.00108	CbGpPWpGaD
Sulfinpyrazone—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.19e-05	0.00106	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—FGFR3—colon cancer	1.18e-05	0.00104	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—AKT1—colon cancer	1.14e-05	0.00101	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.14e-05	0.00101	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.13e-05	0.001	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—APC—colon cancer	1.08e-05	0.000957	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—BRAF—colon cancer	1.01e-05	0.0009	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.01e-05	0.0009	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—EP300—colon cancer	9.76e-06	0.000866	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—SRC—colon cancer	9.49e-06	0.000842	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.45e-06	0.000838	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	9.41e-06	0.000835	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—ABCB1—colon cancer	9.24e-06	0.00082	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—VEGFA—colon cancer	9.24e-06	0.00082	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	9.16e-06	0.000813	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—NRAS—colon cancer	9.13e-06	0.00081	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—TYMS—colon cancer	9.08e-06	0.000805	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	9.07e-06	0.000805	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.9e-06	0.00079	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	8.86e-06	0.000786	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PPARG—colon cancer	8.72e-06	0.000774	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—TGFB1—colon cancer	8.48e-06	0.000752	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	8.43e-06	0.000748	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	8.2e-06	0.000728	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—PTGS2—colon cancer	8.19e-06	0.000727	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ODC1—colon cancer	8.03e-06	0.000713	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CHST5—colon cancer	8.03e-06	0.000713	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	7.99e-06	0.000709	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—KRAS—colon cancer	7.86e-06	0.000697	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.4e-06	0.000657	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	7.35e-06	0.000652	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—CTNNB1—colon cancer	7.33e-06	0.00065	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	7.33e-06	0.00065	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—ABCB1—colon cancer	7.24e-06	0.000642	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—PIK3CA—colon cancer	7.22e-06	0.00064	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	7.19e-06	0.000638	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—CDKN1A—colon cancer	7.16e-06	0.000635	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—TYMS—colon cancer	7.11e-06	0.000631	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.99e-06	0.00062	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—TP53—colon cancer	6.98e-06	0.000619	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PTGS2—colon cancer	6.86e-06	0.000609	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—EP300—colon cancer	6.81e-06	0.000605	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	6.79e-06	0.000602	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—FGFR3—colon cancer	6.79e-06	0.000602	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—HRAS—colon cancer	6.68e-06	0.000592	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—SRC—colon cancer	6.63e-06	0.000588	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PPARG—colon cancer	6.43e-06	0.00057	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—NRAS—colon cancer	6.37e-06	0.000566	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	6.24e-06	0.000553	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—APC—colon cancer	6.23e-06	0.000553	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.18e-06	0.000548	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	6.03e-06	0.000535	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—MYC—colon cancer	5.94e-06	0.000527	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—TGFB1—colon cancer	5.92e-06	0.000525	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—AKT1—colon cancer	5.9e-06	0.000523	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—BRAF—colon cancer	5.86e-06	0.00052	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—EGFR—colon cancer	5.81e-06	0.000515	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—EP300—colon cancer	5.71e-06	0.000506	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—KRAS—colon cancer	5.49e-06	0.000487	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.48e-06	0.000486	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	5.1e-06	0.000452	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PTGS2—colon cancer	5.06e-06	0.000449	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—PIK3CA—colon cancer	5.04e-06	0.000447	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PPARG—colon cancer	5.04e-06	0.000447	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.03e-06	0.000446	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.86e-06	0.000431	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PTGS2—colon cancer	4.73e-06	0.00042	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—ABCB1—colon cancer	4.67e-06	0.000414	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—HRAS—colon cancer	4.66e-06	0.000414	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—TYMS—colon cancer	4.59e-06	0.000407	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CTNNB1—colon cancer	4.23e-06	0.000376	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PIK3CA—colon cancer	4.22e-06	0.000375	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—EP300—colon cancer	4.21e-06	0.000373	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CDKN1A—colon cancer	4.14e-06	0.000367	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—AKT1—colon cancer	4.12e-06	0.000365	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.04e-06	0.000359	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PTGS2—colon cancer	3.96e-06	0.000352	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.96e-06	0.000351	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ABCB1—colon cancer	3.95e-06	0.000351	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—EP300—colon cancer	3.94e-06	0.000349	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—TYMS—colon cancer	3.88e-06	0.000345	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—SRC—colon cancer	3.83e-06	0.00034	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—NRAS—colon cancer	3.68e-06	0.000327	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—AKT1—colon cancer	3.45e-06	0.000306	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MYC—colon cancer	3.43e-06	0.000304	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—TGFB1—colon cancer	3.42e-06	0.000304	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—TYMS—colon cancer	3.38e-06	0.0003	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—EGFR—colon cancer	3.35e-06	0.000298	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—EP300—colon cancer	3.3e-06	0.000292	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.29e-06	0.000292	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PPARG—colon cancer	3.25e-06	0.000288	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ABCB1—colon cancer	3.22e-06	0.000286	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—KRAS—colon cancer	3.17e-06	0.000281	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—TYMS—colon cancer	3.16e-06	0.00028	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PIK3CA—colon cancer	3.11e-06	0.000276	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.99e-06	0.000265	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PIK3CA—colon cancer	2.91e-06	0.000258	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PPARG—colon cancer	2.75e-06	0.000244	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—HRAS—colon cancer	2.69e-06	0.000239	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PTGS2—colon cancer	2.56e-06	0.000227	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—AKT1—colon cancer	2.54e-06	0.000226	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PIK3CA—colon cancer	2.44e-06	0.000216	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.43e-06	0.000216	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PPARG—colon cancer	2.4e-06	0.000213	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—AKT1—colon cancer	2.38e-06	0.000211	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PPARG—colon cancer	2.24e-06	0.000199	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PTGS2—colon cancer	2.16e-06	0.000192	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—EP300—colon cancer	2.13e-06	0.000189	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ABCB1—colon cancer	2.12e-06	0.000188	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—TYMS—colon cancer	2.08e-06	0.000185	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—AKT1—colon cancer	1.99e-06	0.000177	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PTGS2—colon cancer	1.89e-06	0.000167	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—EP300—colon cancer	1.8e-06	0.00016	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PTGS2—colon cancer	1.76e-06	0.000156	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3CA—colon cancer	1.57e-06	0.00014	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—EP300—colon cancer	1.57e-06	0.000139	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PPARG—colon cancer	1.48e-06	0.000131	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—EP300—colon cancer	1.47e-06	0.00013	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3CA—colon cancer	1.33e-06	0.000118	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—AKT1—colon cancer	1.28e-06	0.000114	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PTGS2—colon cancer	1.16e-06	0.000103	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3CA—colon cancer	1.16e-06	0.000103	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—AKT1—colon cancer	1.09e-06	9.65e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3CA—colon cancer	1.08e-06	9.61e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—EP300—colon cancer	9.66e-07	8.57e-05	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—AKT1—colon cancer	9.48e-07	8.41e-05	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—AKT1—colon cancer	8.85e-07	7.85e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3CA—colon cancer	7.15e-07	6.34e-05	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—AKT1—colon cancer	5.84e-07	5.18e-05	CbGpPWpGaD
